J. de Sèze

36.9k citations

484 papers · 15.5k indexed · 5 hit papers · h-index 58

Impact in

Pathology and Forensic Medicine top 0.02%
- Multiple Sclerosis Research Studies
Neurology top 0.05%
- Peripheral Neuropathies and Disorders
- Neuroinflammation and Neurodegeneration Mechanisms
- Long-Term Effects of COVID-19
- Autoimmune Neurological Disorders and Treatments

Papers in

Pathology and Forensic Medicine 280
- Multiple Sclerosis Research Studies 261
Neurology 193
- Peripheral Neuropathies and Disorders 151

Co-authors: Patrick Vermersch Brian G. Weinshenker Kazuo Fujihara Nicolas Collongues Tanya Stojkovic Hélène Zéphir Dean M. Wingerchuk Michael Levy
Journals: Neurology (62 papers)Multiple Sclerosis Journal (41 papers)Journal of Neurology (21 papers)Multiple Sclerosis and Related Disorders (19 papers)European Journal of Neurology (14 papers)
Partner nations: France United States Switzerland

In The Last Decade

J. de Sèze

451 papers receiving 15.1k citations

Hit Papers

5 papers align trajectories log scale

Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder 2023 · 82 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Annals of Neurology
2019 New England Journal of Medicine
2018 Journal of Neuroinflammation
2015 Neurology
2008 Archives of Neurology

Peers

Countries citing papers authored by J. de Sèze

Since Specialization

Citations

This map shows the geographic impact of J. de Sèze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. de Sèze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. de Sèze more than expected).

Fields of papers citing papers by J. de Sèze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. de Sèze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. de Sèze. The network helps show where J. de Sèze may publish in the future.

Co-authors

The 25 scholars most cited alongside J. de Sèze, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. de Sèze Line = papers co-authored together J. de Sèze links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	European experience of cladribine tablets in elderly patients with multiple sclerosis: Could it be the last treatment? Multiple Sclerosis Journal - Experimental Translational and Clinical ·J. de Sèze, Chiara Zecca, Giovanni Castelnovo, Xavier Ayrignac, Patrick Vermersch, Claudio Gobbi, Giulia Mallucci, Clarisse Carra‐Dallière, Pierre Labauge, Kévin Bigaut, Laurent Kremer, Nicolas Collongues, Livia Lanotte, Éric Thouvenot, Christine Ernon, Dominique Dive	2025	2
2	A decade of fingolimod in multiple sclerosis: Insights from a large real-world cohort study Revue Neurologique ·Lucas Gauer, Kévin Bigaut, Éric Berger, Marc Debouverie, T. Moreau, J. de Sèze	2023	1
3	Early use of high efficacy therapies in pediatric forms of relapsing-remitting multiple sclerosis: A real-life observational study Multiple Sclerosis and Related Disorders ·Augustin Moreau, Ioanna Kolitsi, Laurent Kremer, Marie Fleury, Livia Lanotte, François Sellal, C. Gaultier, Guido Ahle, Sylvie Courtois, Andreas Fickl, Sohrab Mostoufizadeh, Christel Dentel, Nicolas Collongues, J. de Sèze, Kévin Bigaut	2023	7
4	Rapid Discrimination of Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis Using Machine Learning on Infrared Spectra of Sera International Journal of Molecular Sciences ·Youssef El Khoury, Marie Gébelin, J. de Sèze, Christine Patte‐Mensah, Gilles Marcou, Alexandre Varnek, Ayikoe Guy Mensah‐Nyagan, Petra Hellwig, Nicolas Collongues	2022	8
5	Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 The Journal of Infectious Diseases ·Ludivine Grzelak, Aurélie Velay, Yoann Madec, Floriane Gallais, Isabelle Staropoli, Catherine Schmidt‐Mutter, Marie-Josée Wendling, Nicolás Meyer, Cyril Planchais, David Rey, Hugo Mouquet, Nathalie Reix, Ludovic Glady, Yves Hansmann, Timothée Bruel, J. de Sèze, Arnaud Fontanet, Maria Gonzalez, Olivier Schwartz, Samira Fafi‐Kremer	2021	49
6	How to switch disease-modifying treatments in multiple sclerosis: Guidelines from the French Multiple Sclerosis Society (SFSEP) Multiple Sclerosis and Related Disorders ·Kévin Bigaut, Mikaël Cohen, Françoise Durand‐Dubief, Élisabeth Maillart, Evelyne Planque, Hélène Zéphir, Christine Lebrun‐Frénay, J. de Sèze	2021	16
7	Microglial Cell Morphology and Phagocytic Activity Are Critically Regulated by the Neurosteroid Allopregnanolone: A Possible Role in Neuroprotection Cells ·Valérie Jolivel, Susana Brun, Fabien Binamé, Jérémie Benyounes, Omar Taleb, Dominique Bagnard, J. de Sèze, Christine Patte‐Mensah, Ayikoe Guy Mensah‐Nyagan	2021	36
8	Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti–SARS-CoV-2 Antibodies Neurology Neuroimmunology & Neuroinflammation ·Kévin Bigaut, Laurent Kremer, Thibaut Fabacher, Livia Lanotte, Marie‐Céline Fleury, Nicolas Collongues, J. de Sèze	2021	23
9	A comparative evaluation of different neuromyelitis optica spectrum disorder sets of criteria European Journal of Neurology ·Caroline Papeix, Ysoline Beigneux, Élisabeth Maillart, J. de Sèze, Catherine Lubetzki, Sandra Vukusic, Nicolas Collongues, Romain Marignier	2020	3
10	Efficacy of Satralizumab (SA237) in Subgroups of Patients in SakuraSky: A Phase III Double-Blind, Placebo-Controlled, Add-On Study in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD) Multiple Sclerosis Journal ·Tomohiko Yamamura, Ingo Kleiter, K Fujihara, Jacqueline Palace, Benjamin Greenberg, Beata Zakrzewska‐Pniewska, F. Patti, Tsai C-P., Albert Saiz, Masayuki Haramura, Yukihiro Terada, Yuichi Kawata, J. de Sèze	2020	1
11	Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders Multiple Sclerosis Journal ·Céline Louapre, Evelyne Maillart, Caroline Papeix, Sinéad Zeidan, Damien Biotti, Zoé Lepine, Abir Wahab, Mickaël Zedet, Pierre Labauge, Caroline Tilikete, Julie Pique, Ayman Tourbah, Guillaume Mathey, Dalia Dimitri Boulos, Pierre Branger, Laurent Kremer, Romain Marignier, Nicolas Collongues, J. de Sèze	2020	4
12	Serum-based differentiation between multiple sclerosis and amyotrophic lateral sclerosis by Random Forest classification of FTIR spectra The Analyst ·Youssef El Khoury, Nicolas Collongues, J. de Sèze, Vildan Gulsari, Christine Patte‐Mensah, Gilles Marcou, Alexandre Varnek, Ayikoe Guy Mensah‐Nyagan, Petra Hellwig	2019	22
13	Quantitative and qualitative normative dataset for intraepidermal nerve fibers using skin biopsy PLoS ONE ·Nicolas Collongues, Brigitte Samama, Catherine Schmidt‐Mutter, Ludivine Chamard-Witkowski, Marc Debouverie, Jean‐Baptiste Chanson, Maria Cristina Antal, Karelle Bénardais, J. de Sèze, Michel Velten, Nelly Boehm	2018	23
14	Air pollution by particulate matter PM10 may trigger multiple sclerosis relapses Environmental Research ·Jonathan Le Roux, Denis Bard, Estelle Le Pabic, Claire Ségala, J. Reis, Jean-Claude Ongagna, J. de Sèze, Emmanuelle Leray	2017	66
15	International consensus diagnostic criteria for neuromyelitis optica spectrum disorders Neurology ·Dean M. Wingerchuk, Brenda Banwell, Jeffrey L. Bennett, Philippe Cabre, William M. Carroll, Tanuja Chitnis, J. de Sèze, Kazuo Fujihara, Benjamin Greenberg, Anu Jacob, Sven Jarius, Marco Aurélio Lana–Peixoto, Michael Levy, Jack H. Simon, Silvia Tenembaum, Anthony Traboulsee, Patrick Waters, Kay E. Wellik, Brian G. Weinshenker Hit paper breakdown →	2015	2985
16	Efficacy of rituximab in refractory neuromyelitis optica Multiple Sclerosis Journal ·Nicolas Collongues, David Brassat, Élisabeth Maillart, Pierre Labauge, Jean‐Christophe Ouallet, Clarisse Carra‐Dallière, T. Moreau, Bertrand Bourre, C Papeix, Bruno Brochet, Bertrand Audoin, Sandra Vukusic, J. de Sèze, Romain Marignier, (unknown)	2015	55
17	Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis - results of the placebo-controlled, double-blind, Phase III ORATORIO study mediaTUM (Technical University of Munich) ·Xavier Montalbán, Bernhard Hemmer, Kottil Rammohan, Gavin Giovannoni, J. de Sèze, Amit Bar‐Or, Douglas L. Arnold, Annette Sauter, Algirdas Kakarieka, Donna Masterman, P Chin, Hideki Garren, Jerry S. Wolinsky, Oratorio Clin Investigators	2015	36
18	Aquaporin-4 antibody–negative neuromyelitis optica Neurology ·Romain Marignier, Raphaël Bernard‐Valnet, Pascale Giraudon, Nicolas Collongues, Caroline Papeix, Hélène Zéphir, Gaëlle Cavillon, Véronique Rogemond, Romain Casey, Bernard Frangoulis, J. de Sèze, Sandra Vukusic, Jérôme Honnorat, Christian Confavreux, (unknown)	2013	127
19	Tear analysis in clinically isolated syndrome as new multiple sclerosis criterion Multiple Sclerosis Journal ·Gauthier Calais, G Forzy, C. Crinquette, A Mackowiak, J. de Sèze, Frédéric Blanc, Christine Lebrun‐Frénay, Olivier Heinzlef, Pierre Clavelou, Thibault Moreau, Bernadette Hennache, Hélène Zéphir, Albert Verier, Véronique Neuville, Christian Confavreux, Patrick Vermersch, Patrick Hautecœur	2009	42
20	Autoantibodies against alpha-fodrin in Sjögren's syndrome with neurological manifestations. PubMed ·J. de Sèze, Sylvain Dubucquoi, A.L. Fauchais, É. Hachulla, Torsten Matthias, Didier Lefranc, Pierre‐Yves Hatron, Patrick Vermersch, Torsten Witte	2004	25

About J. de Sèze

J. de Sèze is a scholar working on Pathology and Forensic Medicine, Neurology, Rheumatology, Neurology and Developmental Neuroscience, having authored 484 papers that have together received 15.5k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (261 papers), Peripheral Neuropathies and Disorders (151 papers), Systemic Lupus Erythematosus Research (54 papers), Polyomavirus and related diseases (37 papers), Rheumatoid Arthritis Research and Therapies (22 papers), Hereditary Neurological Disorders (19 papers), Immunotherapy and Immune Responses (16 papers) and Monoclonal and Polyclonal Antibodies Research (15 papers). The work is most often cited by research in Pathology and Forensic Medicine (10.1k citations), Neurology (7.8k citations), Rheumatology (3.5k citations), Neurology (1.1k citations) and Developmental Neuroscience (451 citations). J. de Sèze has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Patrick Vermersch, Brian G. Weinshenker, Kazuo Fujihara, Nicolas Collongues, Tanya Stojkovic, Hélène Zéphir, Dean M. Wingerchuk, Michael Levy, Sven Jarius and Benjamin Greenberg. Their work appears in journals such as Neurology, Multiple Sclerosis Journal, Journal of Neurology, Multiple Sclerosis and Related Disorders and European Journal of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact